Clinical Trials
173 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Seagen Inc.
Study of the Disease Process of Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Role of Genetic Factors in the Development of Lung Disease
National Institutes of Health Clinical Center (CC)
Smartphone-based Telerehabilitation Versus Home-based Inspiratory Muscle Training After Lung Resection in High-risk Patients
Pusan National University Hospital
SUNRAY-01
Eli Lilly and Company
FOREFRONT
AstraZeneca
ARIAN
Fundación GECP
REVOLU
University Hospital, Bordeaux
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
LADOGA
AstraZeneca
ALKAZAR
Nuvalent Inc.
NADIM-ADJUVANT
Fundación GECP
NIVIPI-Brain
Fundación GECP
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Real World Registry for Use of the Ion Endoluminal System
Intuitive Surgical
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Revolution Medicines, Inc.
POLUS
Ain Shams University
LIBRETTO-001
Eli Lilly and Company
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Iovance Biotherapeutics, Inc.
Lung Cancer Screening CT for Firefighters
University of California, San Francisco
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
Instituto Nacional de Cancerologia de Mexico
REZILIENT2
Taiho Oncology, Inc.
DECAMP-2
Boston University
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
Boston University
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Pfizer
REVIVE
AstraZeneca
REZILIENT3
Taiho Oncology, Inc.
AcceleRET-Lung
Hoffmann-La Roche
LOTOS
AstraZeneca
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
ASPECT
University of Aarhus
VALOR
VA Office of Research and Development
COTIRA
University of Aarhus
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
AstraZeneca
Advanced Imaging Holistic Omics Biobank
IRCCS San Raffaele
CC1
Albert Einstein College of Medicine
LIBRETTO-121
Eli Lilly and Company
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Tale EAP
Nuvation Bio Inc.
HYDRA
Leiden University Medical Center
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
TELESCOPE-H
Rutgers, The State University of New Jersey
Lung Cancer Risk and Early Detection in Firefighters
Massachusetts General Hospital
FIRSTLUNG
Delfi Diagnostics Inc.
PALACE
Fundación GECP
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
Qilu Pharmaceutical Co., Ltd.
Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer
Gene Solutions
SPSIPB vs SAPB for Thoracoscopic Surgery
Medipol University